British American Tobacco cuts sales growth
British American Tobacco, the cigarette manufacturer, warned that sales would be lower than expected
Share this:
British American Tobacco, the cigarette manufacturer, warned that sales would be lower than expected due to tighter than expected closures in South Africa, Mexico and Argentina.
Full-year revenue will now be only 1 to 3% higher than last year's instead of the lower limit of 3 to 5% as previously planned by the company.
Full-year revenue will now be only 1 to 3% higher than last year's instead of the lower limit of 3 to 5% as previously planned by the company.
Profits are also expected to achieve "single-digit" percentage growth instead of the "high-digit" growth indicated above.
BAT will continue to pay dividends in the same ratio to earnings as before, citing continued strong growth in its share of the cigarette market despite an industry decline of approximately 7%.
From a chartist’s point of view, the stock price remains stuck in a medium term trading range between 3560p and 2335p. The 50WMA started to flatten out indicating a possible lack of momentum in the coming weeks. The weekly Relative Strength Index (RSI, 14) is around its neutrality area at 50%.
As long as 3560p is resistance, readers may want to expect a new test of the lower end of the range at 2335p. Alternatively, a break above 3560p would call for a reversal up trend with 4580p as target.
Source: GAIN Capital, TradingView
British American Tobacco, the cigarette manufacturer, warned that sales would be lower than expected due to tighter than expected closures in South Africa, Mexico and Argentina.
Full-year revenue will now be only 1 to 3% higher than last year's instead of the lower limit of 3 to 5% as previously planned by the company.
Full-year revenue will now be only 1 to 3% higher than last year's instead of the lower limit of 3 to 5% as previously planned by the company.
Profits are also expected to achieve "single-digit" percentage growth instead of the "high-digit" growth indicated above.
BAT will continue to pay dividends in the same ratio to earnings as before, citing continued strong growth in its share of the cigarette market despite an industry decline of approximately 7%.
From a chartist’s point of view, the stock price remains stuck in a medium term trading range between 3560p and 2335p. The 50WMA started to flatten out indicating a possible lack of momentum in the coming weeks. The weekly Relative Strength Index (RSI, 14) is around its neutrality area at 50%.
As long as 3560p is resistance, readers may want to expect a new test of the lower end of the range at 2335p. Alternatively, a break above 3560p would call for a reversal up trend with 4580p as target.
Source: GAIN Capital, TradingView
Related tags:
The complete CFD trading experience
Award-winning platforms, competitive spreads, low commissions and dedicated support.
We live and breathe the markets and are dedicated to helping traders realise their ambitions as we continue to set the industry bar.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.
Related articles
EUR/USD, GBP/USD Outlook: RSI Hits 2020 Oversold Levels
EUR/USD, GBP/USD Outlook: The EUR/USD daily RSI has fallen to oversold levels last seen in 2020, raising the risk of a reversal across correlated currency pairs, including the US dollar and GBP/USD.
Nikkei breakout accelerates as yen weakness returns
Nikkei has started October with a powerful breakout, helped by renewed yen weakness and strong upside momentum
AUD/USD hammered by US yields and fading RBA hike bets
US yields, dollar strength and fading RBA hike bets have combined to drive AUD/USD to fresh multi-month lows. The macro and technical bias remains bearish, although history suggests parts of the move are now reaching unusually stretched levels.
StoneX Europe Ltd may make third party material available on this website which may contain information included but not limited to the conditions of financial markets. The material is for information purposes only and does not contain, and should not be construed as containing, investment advice and/or investment recommendation and/or an investment research and/or an offer of or solicitation for any transactions in financial instruments; any decision to enter into a specific transaction shall be made by the client following an assessment by him/her of their situation.
StoneX Europe Ltd makes no representation or warranty and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast or other information supplied. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. We are not under any obligation to update any such material. Any opinion made may be personal to the author and may not reflect the opinion of StoneX Europe Ltd.